Document is current
Any future updates will be listed below
-
Authors
Patel, Tushar P. https://orcid.org/0000-0002-7823-2579
Jun, Joo Yun
Seo, Arnold Y.
Levi, Noah J. https://orcid.org/0000-0002-2854-9113
Elizondo, Diana M.
Chen, Jocelyn
Wong, Adrian M. https://orcid.org/0000-0003-3919-0705
Tugarinov, Nicol https://orcid.org/0000-0003-0918-9172
Altman, Elizabeth K.
Gehle, Daniel B. https://orcid.org/0000-0003-4629-7615
Jung, Sun Min
Patel, Pooja
Ericson, Mark
Haskell-Luevano, Carrie
Demby, Tamar C.
Cougnoux, Antony
Wolska, Anna https://orcid.org/0000-0001-9479-0741
Yanovski, Jack A. https://orcid.org/0000-0001-8542-1637
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD000641)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124504)
Supplemental support from an NIH Bench-to-Bedside award made possible by the NIH Office of Clinical Research.
- License Information
-
More Information
Article History
Received: 17 December 2022
Accepted: 5 February 2025
First Online: 16 February 2025
Competing interests
: J.A.Y. receives grant support unrelated to this article for pharmacotherapy trials for human obesity from Hikma Pharmaceuticals, Inc., Soleno Therapeutics, Inc., and Rhythm Pharmaceuticals, Inc., and reagents (anti-activin receptor antibodies) from Versanis Bio for mouse studies. The remaining authors declare no competing interests.
